about
G protein signaling modulator-3: a leukocyte regulator of inflammation in health and diseaseAn update on dry eye disease molecular treatment: advances in drug pipelines.[Safe use of biological therapies for the treatment of rheumatoid arthritis and spondyloarthritides].Evaluation of destruction in a collagen-induced arthritis rat model: Bony spur formation.The class II transactivator (CIITA) is regulated by post-translational modification cross-talk between ERK1/2 phosphorylation, mono-ubiquitination and Lys63 ubiquitination
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cellular targeting in autoimmunity
@ast
Cellular targeting in autoimmunity
@en
Cellular targeting in autoimmunity
@nl
type
label
Cellular targeting in autoimmunity
@ast
Cellular targeting in autoimmunity
@en
Cellular targeting in autoimmunity
@nl
prefLabel
Cellular targeting in autoimmunity
@ast
Cellular targeting in autoimmunity
@en
Cellular targeting in autoimmunity
@nl
P2093
P2860
P1476
Cellular targeting in autoimmunity
@en
P2093
Donald S. Serafin
Jennifer L. Rogers
Roman G. Timoshchenko
Teresa K. Tarrant
P2860
P2888
P304
P356
10.1007/S11882-012-0307-Y
P407
P577
2012-12-01T00:00:00Z
P5875
P6179
1008890758